Teladoc Health Reports Fourth-Quarter and Full-Year 2019 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/29/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- McKesson reports cybersecurity incident affecting its information systems
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- BioNTech ends colorectal cancer mRNA therapy trial early
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Pinterest CFO resigns, interim replacement named
Teladoc (TDOC) PT Raised to $150 at Cowen
February 27, 2020 6:30 AM ESTCowen analyst Charles Rhyee raised the price target on Teladoc (NYSE: TDOC) to $150.00 (from $100.00) while maintaining an Outperform rating.
The analyst commented, "What's not to like? TDOC's 4Q19 results and 2020 guidance were both better than expected, and we see several potential near-term... More
Teladoc (TDOC) PT Raised to $140 at RBC Capital
February 27, 2020 6:20 AM ESTRBC Capital analyst Sean Dodge raised the price target on Teladoc (NYSE: TDOC) to $140.00 (from $110.00) while maintaining an Outperform rating.
The analyst commented, "Results were better than expected across all metrics. Most notably, mgmts 2020 revenue guide implies 27% growth at MP, topping the 24-25%... More
